GlaxoSmithKline's Alli, the first over-the-counter diet pill approved by the Food and Drug Administration, should be on store shelves in June.

Related articles:

Business in Brief Business in brief Business in Brief Business in Brief Business in Brief Business in brief Business in Brief Business in Brief Business in Brief Business in Brief

Health Care
Sierra Tucson
Eating Disorders Program Coordinator Administrative & Professional
Jorgensen Brooks Group
Counselor Health Care
Dependable Health Services
Physical Therapists Construction
West-Press
Printing Health Care
CENTRAL ARIZONA COLLEGE
DIRECTOR OF HEALTH INFORMATION MANAGEMENT Mechanical
Komatsu Equipment Co
Resident Field Mechanic Administrative & Professional
Tucson Urban League
CEO/President

NEW YORK — You won't lose weight in your sleep or shed pounds while eating anything you want — that's the sobering message from the maker of a weight-loss pill poised to hit shelves next month.

GlaxoSmithKline on Tuesday opened an educational exhibit in New York City to prepare the country for Alli, the first over-the-counter diet pill approved by the Food and Drug Administration.

While the cautionary marketing approach may not trigger stampedes to the counter, analysts say the drug's fate hinges on the pharmaceutical giant's ability to convince people that diet pills aren't a magic bullet.

In clinical trials, the FDA says that people using Alli lost an additional 2 to 3 pounds for every 5 pounds lost through diet and exercise. The FDA approved Alli to be sold over the counter in February.

NEW YORK — Oil prices dropped below $65 a barrel as investors sold contracts before their expiration Tuesday, and before the government's weekly inventory report.

News of a partial oil production shutdown in Alaska and a government report predicting a busy hurricane season failed to boost prices.

The June contract for light, sweet crude, which expired Tuesday, lost $1.30 to settle at $64.97 a barrel on the New York Mercantile Exchange. The July contract also fell $1.36 cents to close at $65.51 a barrel.

July Brent crude slipped 97 cents to settle at $69.52 a barrel on the ICE Futures exchange.

Concerns ahead of the high-demand summer driving season in the U.S. have propped up prices lately, despite expectations that a snapshot of inventories due for release today could show the third increase in gasoline stocks in as many weeks.

CINCINNATI — Liquid detergents made by the Procter & Gamble Co. for distribution in North America will be sold in double-strength concentrations by April, the company said Tuesday.

That will mean smaller containers easier for consumers to handle, and will decrease the volume of packaging to be warehoused and, ultimately, disposed of in landfills, the consumer products company said.

The brands include Tide, Gain, Cheer, Era and Dreft liquid. The rollout in the southern U.S. and Puerto Rico will begin in September and will be completed by April in the Northeast and Canada.

The concentrated detergents provide consumers with the same number of loads in a detergent bottle half the size, the company said.

Shares of MGM Mirage surged the most since 1989 after billionaire Kirk Kerkorian said he wants to buy the company's Bellagio Hotel & Casino in Las Vegas.

MGM Mirage Inc.'s board of directors met Tuesday for the first time since Tracinda Corp., Kerkorian's investment firm, announced Monday that it wanted to enter talks to buy two MGM Mirage properties and perhaps restructure the giant casino company.

MGM Mirage was expected to form a committee of non-management, non-Tracinda board members to consider Kerkorian's proposal to buy The Bellagio Hotel and Casino and CityCenter properties.

Bellagio is the jewel in the crown of MGM Mirage's Las Vegas Strip properties, accounting for roughly 20 percent of its operating profits. CityCenter is its $7.4 billion megaresort being built next door and set to open in late 2009.

MGM shares rose 27 percent, or $17.03, to $79.98 Tuesday.